FDA-approved

Bones & muscles

Teriparatide

Evidence

FDA approved

Class

Parathyroid hormone fragment (1-34)

/

Teriparatide

KEY TAKEAWAY

Teriparatide is a fragment of parathyroid hormone that builds new bone. It is approved to treat osteoporosis in people at high risk of fracture.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A bone-building fragment of parathyroid hormone

Approved for

Osteoporosis in people at high fracture risk

Key fact

Reduced new vertebral fractures in postmenopausal women

Route

Daily injection

Evidence strength

FDA approved

What it is

What it is

Teriparatide, sold as Forteo, contains the first 34 amino acids of human parathyroid hormone.

How it works

How it works

Given in daily pulses it stimulates bone-forming cells more than bone-resorbing cells, increasing bone density.

Regulatory status

Regulatory status

The FDA approved teriparatide in 2002 for osteoporosis. An earlier boxed warning about osteosarcoma seen in rats was removed in 2020.

What it is used for

What it is used for

Postmenopausal osteoporosis, osteoporosis in men and glucocorticoid-induced osteoporosis.

Side effects and risks

Side effects and risks

Nausea, leg cramps, dizziness and raised calcium levels can occur. Treatment is generally limited to about two years.

Citations

Citations

Neer RM et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo